-
CRISPR Therapeutics' (CRSP) Market Outperform Rating Reiterated at JMP Securities
来源: Buzz FX / 13 2月 2025 10:36:10 America/New_York
CRISPR Therapeutics' (CRSP) Market Outperform Rating Reiterated at JMP Securities Written by MarketBeat February 13, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "market outperf
Read more...